The possible reason is that TACE can cause ischemic tumor necrosis, thus reducing tumor burden, resulting in tumor tissue release of tumor antigen, increased expression of PD-1 and PD-L1, and improved tumor recognition. Here, CD274 is linked to neoplasm.